Market Size of Global Digital Dose Inhaler Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 13.30 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Digital Dose Inhaler Market Analysis
The digital dose inhaler market is anticipated to grow with a CAGR of above 13.3% during the forecast period.
COVID-19 pandemic had a significant impact on the global digital dose inhaler market, due to patients with asthma and chronic obstructive pulmonary disease (COPD) being considered at increased risk of hospitalization from COVID-19. According to the article titled "Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study" published in January 2022 adults with asthma were found to be at an increased risk of COVID-19 hospital admission compared with those without asthma conditions. Thus, increasing cases of COVID-19 are rising the cases of respiratory disorders which generates the need for digital dose inhalers. Thus COVID-19 had a significant impact on the growth of the market during the pandemic period.
The major factors attributing to the growth of the digital dose inhaler market include the rising prevalence of chronic respiratory diseases and the growing demand for technology-enabled features of respiratory devices.
Soaring geriatric populations suffering from respiratory disorders and favorable reimbursement policies also play a significant role in the growth of the market. According to the article titled "Common Respiratory Disorders in Seniors" published in April 2020 around 15% of older adults from asthma, chronic obstructive pulmonary disease, or another respiratory disorder. The rising prevalence of respiratory diseases globally is expected to drive the demand for digital dose inhalers, thereby contributing to the growth of the market.
Additionally, the increasing product launches are expected to contribute to the growth of the market. For instance, in December 2021 NuvoAir, launched an add-on sensor for asthma and chronic obstructive pulmonary disease inhalers as a part of its chronic care ecosystem.
Thus, the above-mentioned factors are expected to drive the growth of the market over the forecast period. However, the high cost of the inhalers is a constraint to the growth of the market.
